Substance / Medication

Oil of garlic

Overview

Active Ingredient
oil of garlic
RxNorm CUI
1309210

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.
Mousavi Asma, Shojaei Shayan, Abhari Amir Parsa et al. · Am J Hypertens · 2026
PMID: 40717314Meta-Analysis
The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: A Systematic Literature Review and Data Analysis.
Møller Charlotte Agergaard, Nielsen Steffen Flindt, Mose Frank Holden · Am J Hypertens · 2026
PMID: 40717316Meta-Analysis
Arterial spin labeling MRI in assessing cerebral blood flow changes due to hypertension: a systematic review.
Muthu Sathya Sabina, Sukumar Suresh, Kadavigere Rajagopal et al. · J Hypertens · 2026
PMID: 41002015Meta-AnalysisFull text (PMC)
The intergenerational effects of low parental socio-economic position on cardiometabolic and inflammatory outcomes: A systematic review and meta-analysis.
Rivillas-García Juan Carlos, Courtin Emilie, Winpenny Eleanor et al. · Eur J Clin Invest · 2026
PMID: 41020493Meta-AnalysisFull text (PMC)
QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic.
Camargo Alejandra B, Marchevsky Eduardo, Luco Juan M · J Agric Food Chem · 2007
PMID: 17367159Other
[Analysis of volatile oil of garlic by gas chromatography-mass spectrometry].
Guo Xiaofei, Du Ailing, Guan Congsheng et al. · Se Pu · 2005
PMID: 16350805Other
The oil of garlic, Allium sativum L. (Amaryllidaceae), as a potential protectant against Anisakis spp. Type II (L3) (Nematoda) infection in Wistar rats.
Morsy Kareem, Ghamdi Ali Al, Dajem Saad Bin et al. · Rev Bras Parasitol Vet · 2021
PMID: 33605386Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oil of garlic (substance)
SNOMED CT
20507001
UMLS CUI
C1802750
RxNorm CUI
1309210

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.